Jin Rong Jie·2025-08-06 18:56Core Viewpoint - Lijun Group's stock price has decreased by 2.14% to 40.66 yuan as of August 6, 2025, with a trading volume of 111,257 hands and a transaction amount of 456 million yuan [1] Company Summary - Lijun Group is primarily engaged in the research, production, and sales of pharmaceutical products, covering areas such as chemical preparations, active pharmaceutical ingredients, intermediates, diagnostic reagents and equipment, and biological products [1] - In the first quarter of 2025, Lijun Group achieved an operating revenue of 3.181 billion yuan and a net profit attributable to shareholders of 637 million yuan [1] - On August 6, 2025, Lijun Group repurchased 73,100 A-shares through centralized bidding, with a repurchase price range of 40.54 yuan to 41.55 yuan per share, totaling a payment amount of 3 million yuan [1]